CHEK1 and malignant colon neoplasm: In this study, we used the high-throughput screening method described by Morano et al. [30] to identify molecules that block ATR/Chk1 signaling by inhibiting TopBP1 focus formation in colon cancer cells exposed to topoisomerase I inhibitors.